PubMed · 1973 · 23 citations · 18 references
MedicineImmunologyOncologyCancer ImmunologyTumor ImmunologyVaccinologyCancer ImmunotherapyCancer VaccinesHumoral ImmunityImmunotherapy For Skin CancerBenign Tumor PromotionImmunization With Bacille Calmette-guérinImmunogenicity Of Tumor AntigensSkin ImmunizationSkin Tumor PromotionTherapeutic Cancer ImmunizationTumor Antigen ImmunogenicityTumor Immunogenicity
Summary Charles River mice were painted once with dimethylbenz(a)anthracene (tumor initiation), followed by repeated applications of croton oil (tumor promotion). The i.v. injection of Bacillus Calmette-Guerin (BCG) 3 weeks prior to the initiation of croton oil treatment reduced the incidence and rate of appearance of both benign and malignant skin tumors. After 50 applications of croton oil, (2/week for 25 weeks), it was possible to demonstrate that the BCG-treated mice without tumors had a smaller spleen index and showed a greater cell-mediated immunological responsiveness to purified protein derivative than did the BCG-treated mice with the greatest number of tumors in the same group. Tubercle organisms were isolated from spleen cultures of the BCG-treated mice, regardless of their capacity to respond to in vivo and in vitro tests with purified protein derivative as antigen.
18
Immunological factors which influence response to immunotherapy in malignant melanoma.
D L Morton, Frederick R. Eilber, R. A. Malmgren et al. · PubMed · 1970 · 466 citations
Medicine, Immunology, Oncology +14
B.C.G. VACCINATION AND LEUKÆMIA MORTALITY
Lise Davignon, P.-Y. Robillard, P Lemonde et al. · The Lancet · 1970 · 230 citations